Hamilton Thorne

Beverly, United States Founded: 2002 • Age: 24 yrs Listed Acquired By Astorg Partners
Precision laser devices and advanced image analysis systems for the fertility, stem cell and development biology

About Hamilton Thorne

Hamilton Thorne is a Healthcare company based in Beverly (United States) founded in 2002, and was acquired by Astorg Partners in July 2024. It operates as a precision laser devices and advanced image analysis systems for the fertility, stem cell and development biology. Hamilton Thorne has completed 5 acquisitions, including Embryotech Laboratories, GYNEMED and MICROPTIC. Hamilton Thorne offers products and services including CASA Systems, Laser Systems, and Oosight Imaging System. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Diversified. Its legal entity is Hamilton Thorne Inc. Its competitors include Cepheid, Beckman Coulter, Bruker, Blackrock Neurotech and Esco Lifesciences and 4 more; 5 of its 9 listed competitors have raised funding.

Company details

Founded in 2002 and located in Beverly, United States, precision laser devices and advanced image analysis systems are supplied for fertility, stem cell, and developmental biology sectors. Laser products, numbering five with others in development, attach to inverted microscopes for IVF procedures and scientific applications as robotic tools. CASA systems facilitate reproductive cell analysis in human fertility, animal sciences, and toxicology. Customers include academic and pharmaceutical research labs.

Key Metrics

Products & Services of Hamilton Thorne

Hamilton Thorne offers a comprehensive portfolio of products and services, including CASA Systems, Laser Systems, and Oosight Imaging System.

CASA Systems
Sperm Analysis

Tools for analyzing sperm motility in fertility studies

Laser Systems
IVF Equipment

Devices for precise cellular manipulation in ART procedures

Oosight Imaging System
Imaging Tools

System for high-contrast oocyte imaging in reproductive research

Apps and channels of Hamilton Thorne

its YouTube channel Hamilton Thorne has 459 subscribers and 30 videos.

Hamilton Thorne
YouTube 459 subscribers 30 videos Science & Technology
Open channel

Videos from Hamilton Thorne

The most watched videos on Hamilton Thorne's YouTube channel, Hamilton Thorne (459 subscribers). Click a video to play it here.

IMSI-Strict High Resolution Sperm Acquisition
57.6K views
Trophectoderm Biopsy using Hamilton Thorne laser
9.2K views
Artificial Intelligence in the ART Laboratory
7.6K views
IVOS II Playback & Zoom
5.5K views

More on Hamilton Thorne.

Funding Insights of Hamilton Thorne

  • Total Rounds 8
  • Last Round Post-IPO β€” $5.1M
  • First Round $349,895

    (May 2012)

All 8 funding rounds of Hamilton Thorne with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2020$5.1MPost-IPO––
–
Sep 2019$7.5MDebt – Conventional––
–
Sep 2018$10MPost-IPO––
–
Oct 2017$150,000Post-IPO––
–
May 2017$9.15MPost-IPO––
–
Jun 2015$1.23MPost-IPO––
–
Nov 2014$660,659Post-IPO––
–
May 2012$349,895Post-IPO––
–
Valuation history

1 investors in total: 1 institutional.

Investors in Hamilton Thorne

Hamilton Thorne has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Astorg.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Astorg is engaged in private equity investment management.
–astorg.comParis, France
Premium access

Investor details for Hamilton Thorne

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Hamilton Thorne

13 people are tracked at Hamilton Thorne (7 in leadership, 6 in team).

NameRoleGroup
Sio Tufuga
Regional Sales Director, SouthwestLeadership
Kate Craig
VP, Global Research & CASA SalesLeadership
Scott Collins
Regional Sales DirectorLeadership
Michael Magee
Regional Sales DirectorLeadership
Brian Leonard
VP, Sales Clinical Markets AmericasLeadership
Lisa Ng
VP, Sales Asia PacificLeadership
Casey Cummins
Regional Sales DirectorLeadership
Nicole Miller
Senior Inside Sales RepresentativeTeam
Kim Pellitier
Sales AdministratorTeam
Brett Fulton
SVP & GMTeam
Catherine Welch Mi
Regional Sales ManagerTeam
Jill Bouley
Sales AdministratorTeam
Susan Delaney
Sales DelaneyTeam
Premium access

Complete people profiles for Hamilton Thorne

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Hamilton Thorne

Hamilton Thorne has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Embryotech Laboratories, GYNEMED and MICROPTIC.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Semen analyzers, FISH kits, and disposable counting chambers are manufactured.
micropticsl.comBarcelona, Spain1989Dec 2022β€’β€’β€’β€’
Medical devices are manufactured and distributed globally from Australia.
tekevent.comSydney, Australia2002May 2021β€’β€’β€’β€’
Laboratory products are manufactured for scientific and research applications.
planer.com–1973Aug 2019$10.62M
Manufacturer of clinical laser, micro manipulation, incubation, air purification & microscopy systems
gynemed.de–1998Apr 2017$15.14M
Toxicity testing assays
embryotech.comHaverhill, United States1994Sep 2016$7.25M
Premium access

Complete acquisition details for Hamilton Thorne

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Hamilton Thorne

10 dated milestones of Hamilton Thorne across 22 years, from founding to its latest funding, stage changes and deals.

  1. Founded Hamilton Thorne is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round of $350K.
  4. Acquisition Acquires Embryotech Laboratories.
  5. Acquisition Acquires GYNEMED.
  6. Acquisition Acquires Planer.
  7. Funding Latest funding round, Post-IPO, of $5.1M.
  8. Acquisition Acquires Tek-Event.
  9. Acquisition Acquires MICROPTIC.
  10. Exit Acquired by Astorg Partners.

Competitors of Hamilton Thorne

Hamilton Thorne has 9 listed competitors in our database, 5 of them funded. They include Cepheid, Beckman Coulter, Bruker, Blackrock Neurotech and Esco Lifesciences, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cepheid.com1996Sunnyvale, United States$19.1M1,299
Developer of molecular diagnostic testing solutions
beckman.com1935Brea, United States––
Provider of products for biomedical testing for R&D, diagnostic and commercial applications
bruker.com1960United States–9,707
Diversified research instrument systems are manufactured and supplied.
blackrockneurotech.com2008Salt Lake, United States$22.37M127
Medical devices for neurological therapies are developed.
escolifesciences.com1978Singapore$400M–
Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools
unchainedlabs.com2015Pleasanton, United States$111M–
Multiplex protein stability platform for biologics is developed.
waters.com1958Milford, United States–9,341
Provider of laboratory management system for researchers and clinicians
sartorius.com1870Gottingen, Germany–566
Laboratory and biopharmaceutical equipment is developed for production processes.
fluidigm.com1999San Francisco, United States$40.53M205
Instruments for life sciences research and applications are developed.
Premium access

Detailed competitors of Hamilton Thorne

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Hamilton Thorne

The website of Hamilton Thorne (hamiltonthorne.com) receives about 5.6K visits a month.

  • Monthly visits
    5.6K

    ▼ 9.6% vs previous month

Similar websites

Websites whose visitors overlap most with Hamilton Thorne. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
ivf.net
ivf.net
100%
–#1,246,688–
mes-global.com
76%
–#2,210,443View details
pasteur.edu.uy
pasteur.edu.uy
56%
–––
medtechdive.com
medtechdive.com
43%
–#345,845–
coopersurgical.com
29%
–#414,385View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 6 similar websites and full traffic analytics for Hamilton Thorne

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 6 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

10 companies that operate in the same segment as Hamilton Thorne (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B–1,111
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.34 BUSD 301.49 M1,372
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Hamilton Thorne

Premium access

Complete news archive for Hamilton Thorne

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hamilton Thorne

Hamilton Thorne was founded in 2002 and raised its 1st funding round 10 years after it was founded.

Hamilton Thorne is headquartered in Beverly, United States. It is registered at Beverly, Massachusetts, United States.

Founded in 2002 and located in Beverly, United States, precision laser devices and advanced image analysis systems are supplied for fertility, stem cell, and developmental biology sectors. Laser products, numbering five with others in development, attach to inverted microscopes for IVF procedures and scientific applications as robotic tools. CASA systems facilitate reproductive cell analysis in human fertility, animal sciences, and toxicology. Customers include academic and pharmaceutical research labs.

Hamilton Thorne's top competitors include Cepheid, Blackrock Neurotech and Esco Lifesciences.

Hamilton Thorne offers CASA Systems, Laser Systems, and Oosight Imaging System.

Hamilton Thorne has made 5 acquisitions, including Embryotech Laboratories, GYNEMED, and MICROPTIC.

Hamilton Thorne has 1 investor. Key investors include Astorg.

Hamilton Thorne operates through Hamilton Thorne Inc..

Yes. Hamilton Thorne was acquired by Astorg Partners in July 2024.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available